RARE DISEASES A–Z · LETTER M

Myasthenia Gravis

Myasthenia gravis (MG) is an autoimmune condition of the nerve–muscle junction: antibodies interfere with the receptors that receive the nerve's signal, so muscles tire abnormally fast. It is the commonest disorder of neuromuscular transmission, and one of the most treatable neurological conditions.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Myasthenia gravis is an autoimmune attack on the muscle's acetylcholine receptors, causing weakness that worsens with use and improves with rest — eyes first, sometimes breathing at worst. Pyridostigmine, immune treatment, and thymectomy control it well.

The guide

The basics

After each nerve impulse, the receptor patch on the muscle should catch the acetylcholine signal and trigger contraction. In MG, antibodies block, damage, and reduce those receptors, so the signal fades with repeated use — the defining feature is fatigable weakness that improves with rest. The eyes are usually first: a drooping eyelid and double vision that vary through the day. Generalised disease adds slurred, nasal speech after talking, chewing that tires mid-meal, difficulty swallowing, weak neck and limb muscles (worse later in the day), and, at worst, breathing failure — myasthenic crisis. Most patients have antibodies against the acetylcholine receptor; smaller groups have anti-MuSK or anti-LRP4 antibodies, which behave somewhat differently, and some have none detectable. The thymus gland is involved in driving the immune error in many.

How it works

Antibody blood tests confirm most cases — acetylcholine receptor antibodies in the majority, MuSK or LRP4 in many of the rest. Electrical studies are the other pillar: repetitive nerve stimulation shows the signal fading with repeated impulses, and single-fibre EMG, the most sensitive test, shows jittery transmission at individual junctions. An ice-pack test on a drooping eyelid (it briefly improves) is a neat bedside clue. CT or MRI of the chest looks for thymoma. Thyroid and other autoimmune screening accompanies the work-up. Where all tests are negative but the picture is classic, specialists diagnose seronegative MG on clinical and electrical grounds.

Day to day

Treatment works on three levels. Symptomatic: pyridostigmine tablets slow the breakdown of acetylcholine, giving each signal more chances to land — the first-line, fast-acting help. Immune-directed: corticosteroids and steroid-sparing immunosuppressants reduce antibody production; thymus removal (thymectomy) improves outcomes in many people with generalised disease and is required if a thymoma is present. Rapid or rescue therapy for severe weakness or crisis: plasma exchange or intravenous immunoglobulin in hospital, with breathing support as needed. Newer targeted treatments — complement inhibitors and FcRn blockers that accelerate antibody removal — have expanded options for refractory disease. With modern care, most people achieve good control and a normal lifespan.

When to get help

Reviews track strength, breathing measures, antibody type, and treatment side effects. Know your crisis symptoms (see the red flag) and keep an up-to-date medicine list — several common drugs, including some antibiotics and beta-blockers, can worsen MG, so every prescriber and anaesthetist should know the diagnosis. Vaccinations, especially against flu and pneumococcal disease, are encouraged because infections are the commonest crisis trigger; live vaccines need discussion if you are immunosuppressed. Pregnancy planning benefits from a neurology-obstetric conversation in advance. Most people with well-managed MG work, drive (once vision is stable and cleared), and live a normal lifespan.

See a doctor promptly if: Difficulty breathing, inability to swallow saliva, or rapidly worsening weakness in someone with MG can be a myasthenic crisis — call emergency services immediately.

Common questions

What does myasthenia gravis mean?

It means 'grave muscle weakness' in Latin and Greek — a name from the era before treatment, when the condition was often fatal. With modern therapy most people do far better than the name suggests, though the condition still demands respect.

Why does the thymus matter?

The thymus — a gland in the chest that trains immune cells — is abnormal in most people with MG: enlarged in many younger patients, and harbouring a tumour (thymoma) in a minority. Removing it improves the disease course in many and is essential when a thymoma is present, which is why chest imaging is part of every work-up.

Can myasthenia gravis go into remission?

It depends on the antibody and the person. Some people, particularly those treated early with thymectomy and immunotherapy, achieve long remissions; others need continuing treatment. MuSK-antibody disease behaves differently and responds to different treatments — one reason antibody typing guides care.

Are there medicines I should avoid?

Yes. Certain antibiotics, beta-blockers, magnesium, and some other medicines can unmask or worsen MG. Carry a list of your diagnosis and medicines, check new prescriptions against MG caution lists, and make sure anaesthetists know before surgery.

More in Letter M

Related

Sources

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Crisis symptoms and medicine changes are individual; follow your neurology team's plan and carry your MG medication list.